Mechanistically, they revealed that TET2 could be recruited by STAT1 to hydroxymethylate the PD-L1 gene promoter and enhance its transcription in murine melanoma and colon tumor upon IFN-gamma stimulation. The gene discussed is STAT1; the disease is melanoma.